Matinas Biopharma Holdings Inc
0.017 (3.13%)
Company Name Stock Ticker Symbol Market Type
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.017 3.13% 0.56 18:49:49
Open Price Low Price High Price Close Price Prev Close
0.57 0.55 0.57 0.5689 0.543
more quote information »

Recent News

Date Time Source Heading
2/02/20239:58IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly.
2/02/20239:30IHNWFeaturedHempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products
2/02/20237:03IHNWFeaturedAmerican Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow
1/30/202316:01EDGARCurrent Report Filing (8-k)
1/30/202316:01GLOBEMatinas BioPharma Provides Business Update and 2023..
1/23/202307:00GLOBEMatinas BioPharma to Provide Corporate Update and 2023..
1/12/202307:00EDGARCurrent Report Filing (8-k)
1/12/202307:00GLOBEMatinas BioPharma Announces Collaboration with National..
12/22/202211:25EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202211:24EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202211:22EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202211:20EDGARStatement of Changes in Beneficial Ownership (4)
12/22/202211:19EDGARStatement of Changes in Beneficial Ownership (4)
11/14/202217:44EDGARCurrent Report Filing (8-k)
11/02/202216:03EDGARQuarterly Report (10-q)
11/02/202216:02GLOBEMatinas BioPharma Reports Third Quarter 2022 Financial..
10/27/202207:00GLOBEMatinas BioPharma to Webcast Conference Call Discussing..
10/21/202207:48GLOBEMatinas BioPharma Announces Positive Interim Data from the..
10/21/202207:02EDGARCurrent Report Filing (8-k)
10/21/202207:00GLOBEMatinas BioPharma to Present at the ThinkEquity Annual..
10/19/202207:10GLOBEMatinas BioPharma Announces Infectious Diseases Society of..
10/12/202207:00GLOBEMatinas BioPharma to Present New MAT2203 (Oral Amphotericin..
9/22/202217:02EDGARProxy Statement (definitive) (def 14a)
9/21/202207:00GLOBEMatinas BioPharma Announces Chairman Succession Plan
9/13/202207:01EDGARCurrent Report Filing (8-k)
9/07/202207:00GLOBEMatinas BioPharma to Present at the H.C. Wainwright 24th..
8/12/202211:35TRMNMaxim Group Sticks to Their Buy Rating for Matinas BioPharma..
8/12/202206:26TRMNH.C. Wainwright Remains a Buy on Matinas BioPharma (MTNB)
8/11/202206:30GLOBEMatinas BioPharma Reports Second Quarter 2022 Financial..
8/01/202207:00GLOBEMatinas BioPharma to Participate in the BTIG Biotechnology..
7/28/202216:15GLOBEMatinas BioPharma to Webcast Conference Call Discussing..
7/25/202206:30GLOBEMatinas BioPharma Announces Positive Opinion by the European..
7/14/202203:05TRMNBTIG Remains a Buy on Matinas BioPharma (MTNB)
7/05/202218:01EDGARStatement of Changes in Beneficial Ownership (4)
5/31/202207:00GLOBEMatinas BioPharma to Present at the LD Micro Invitational..
5/13/202214:25TRMNMatinas BioPharma (MTNB) Initiated with a Buy at Maxim Group
5/13/202206:26TRMNH.C. Wainwright Thinks Matinas BioPharma’s Stock is Going to..
5/12/202206:32EDGARCurrent Report Filing (8-k)
5/12/202206:30GLOBEMatinas BioPharma Reports First Quarter 2022 Financial..
5/12/202206:26EDGARQuarterly Report (10-q)
5/05/202207:00GLOBEMatinas BioPharma to Webcast Conference Call Discussing..
5/03/202207:00GLOBEMatinas BioPharma to Present at the 12th Annual BioNJ..
4/13/202208:44EDGARCurrent Report Filing (8-k)
4/12/202214:25TRMNMatinas BioPharma (MTNB) Receives a Buy from Maxim Group
4/11/202211:05TRMNH.C. Wainwright Sticks to Its Buy Rating for Matinas..
4/11/202207:00EDGARCurrent Report Filing (8-k)
4/11/202207:00GLOBEBioNTech and Matinas BioPharma Announce Exclusive Research..
4/06/202207:00GLOBEMatinas BioPharma to Present at the Needham Virtual..
4/01/202217:26EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/22/202207:00GLOBEMatinas BioPharma to Participate in the 2022 Virtual Growth..
3/19/202205:12TRMNBTIG Maintains Their Buy Rating on Matinas BioPharma (MTNB)
3/11/202216:00EDGARAmended Annual Report (10-k/a)
3/08/202206:33SEEKMatinas Biopharma GAAP EPS of -$0.03 beats by $0.01